Neuroscience
Adenylyl Cyclase
100%
Degranulation
36%
Dura Mater
27%
Headache
100%
Hypophysis Adenylate Cyclase Activating Polypeptide
72%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
63%
In Vitro
9%
Lecithinase
27%
Mast Cell
45%
Mast Cell Degranulation
100%
Migraine
18%
PAC-1
18%
Receptor
18%
Skull
9%
Vasoactive Intestinal Peptide
72%
Medicine and Dentistry
Acetic Acid Derivative
10%
Clinical Study
10%
Degranulation
40%
Dura Mater
30%
Headache
100%
Hypophysis Adenylate Cyclase Activating Polypeptide
80%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
70%
In Vitro
10%
Lecithinase
20%
Mast Cell
50%
Migraine
20%
Peritoneum
10%
Phospholipase C Inhibitor
10%
Pituitary Adenylate Cyclase-Activating Polypeptide
100%
Receptor
20%
Vasoactive Intestinal Polypeptide
80%
Keyphrases
A1 Receptor
11%
Degranulation
23%
Dura Mater
17%
Dural
100%
Headache
100%
Intracellular Signaling
5%
Mast Cell Degranulation
100%
Mast Cells
11%
Migraine
11%
Migraineurs
5%
N-acetylation
5%
PAC1
11%
Peritoneum
5%
Phospholipase C
17%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
100%
Signal Transduction Pathway
5%
Skull
5%
Truncated Version
5%
U73122
5%
Vasoactive Intestinal Peptide
47%
β-hexosaminidase
5%
Biochemistry, Genetics and Molecular Biology
Adenylate Cyclase
10%
Clinical Study
10%
Degranulation
40%
Hexosaminidase
10%
Lecithinase
30%
Mast Cell
50%
Pituitary Adenylate Cyclase-Activating Polypeptide
100%
Vasoactive Intestinal Peptide
80%
Veterinary Science and Veterinary Medicine
Dura Mater
30%
Mast Cell
100%
Peritoneum
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adenylate Cyclase Inhibitor
10%
Beta N Acetylhexosaminidase
10%
Hypophysis Adenylate Cyclase Activating Polypeptide 27
70%